Catalyst–Substrate Pairings for Carbocyclic and Heterocyclic Systems in Atroposelective Quinazolinone Synthesis
- 7 November 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 14 (23) , 17226-17232
Abstract
Asymmetric catalytic reaction development depends critically on the matching of an appropriate catalytic scaffold with a substrate of interest. In many cases, a catalyst will be discovered to be quite selective for a given substrate, and that same catalyst is then evaluated for its scope with respect to alterations of the substrate. In the context of a catalytic atroposelective cyclocondensation, we discovered that a chiral phosphoric acid catalyst (CPA), (R)-TCYP, mediated these processes with up to 98:2 enantiomeric ratio (er) and in 95% yield. Yet, when the same reaction was attempted in the presence of a basic nitrogen heteroatom within the substrate, enantioselectivity was significantly reduced (73:27 er). In these instances, a different catalyst scaffold based on phosphothreonine (pThr), while ineffective for the carbocyclic substrate (53:47 er), was found to be quite selective (90:10 er) for its pyridyl analog. Mechanistic studies exploring this divergence in reactivity unveiled that the 8-carbocyclic substrate (using (R)-TCYP) displayed a positive nonlinear effect (NLE), whereas the 8-heterocyclic substrate (using a pThr-based catalyst) displayed no NLE at all. The mechanistic distinctions between these two scenarios suggest significant differences in the nature of the noncovalent interactions that operate to deliver high enantioselectivity.Keywords
Funding Information
- Division of Graduate Education (DGE 2139841)
- National Institute of General Medical Sciences (R35 132092)
This publication has 34 references indexed in Scilit:
- Asymmetric Synthesis of Axially Chiral C−N AtropisomersChemistry – A European Journal, 2022
- Quinazoline: An update on current status against convulsionsJournal of Molecular Structure, 2022
- A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discoveryEuropean Journal of Medicinal Chemistry, 2018
- Synthesis, characterization and antimicrobial studies of new 2-(2-chloroquinolin-3-yl)-3-(substituted phenyl/pyridinyl)quinazolin-4(3H)-one derivatives using l-proline as a catalystMedicinal Chemistry Research, 2014
- Revealing Atropisomer Axial Chirality in Drug DiscoveryChemMedChem, 2011
- The Challenge of Atropisomerism in Drug DiscoveryAngewandte Chemie International Edition, 2009
- Asymmetric Brønsted Acid Catalysis: Catalytic Enantioselective Synthesis of Highly Biologically Active DihydroquinazolinonesAngewandte Chemie International Edition, 2009
- “Designer Acids”: Combined Acid Catalysis for Asymmetric SynthesisAngewandte Chemie International Edition, 2005
- Enantioselective Mannich‐Type Reaction Catalyzed by a Chiral Brønsted AcidAngewandte Chemie International Edition, 2004
- Nonlinear Effects in Asymmetric Synthesis and Stereoselective Reactions: Ten Years of InvestigationAngewandte Chemie International Edition, 1998